🔎 Trials Near Me

Home › NCT06394739

RevCore for In Stent Thrombosis

RecruitingObservational study

RevCore for In Stent Thrombosis (REVIT)

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

1. Age ≥ 18 years
2. Patients with stent age \> 6 weeks
3. Location of thrombosed stents in proximal lower extremity deep vein segments including at least common femoral, external iliac, or common iliac vein
4. RevCore Thrombectomy Catheter must enter vasculature
5. Willing and able to provide informed consent

Exclusion Criteria:

1. Exposed stents with broken struts, significantly deformed struts, struts protruding into the vessel
2. Stents not wall apposed
3. Stents compressed to \<10mm
4. Bilateral in-stent thrombosis
5. Congenital anatomic anomalies of the iliac veins
6. Allergy, hypersensitivity, or thrombocytopenia from heparin or iodinated contrast agents, except for mild to moderate contrast allergies for which pretreatment can be used
7. Any contraindication to anticoagulants or antiplatelets that, in the opinion of the Investigator, cannot be medically managed throughout the study period
8. Chronic non-ambulatory status
9. Known hypercoagulable states (e.g. antiphospholipid syndrome) that, in the opinion of the Investigator, cannot be medically managed throughout the study period
10. Inability to secure venous access
11. Subject has any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject
12. Current participation in another investigational drug or device treatment study

About the study

The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.

What is being tested

Sponsor: Inari Medical · Participants: 100 · Started: Sep 9, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06394739

Locations in the U.S.

ConnecticutYale University, New Haven
District of ColumbiaMedstar Health Research Institute, Washington D.C.
IdahoSt. Luke's Hospital Boise, Boise
New YorkNew York University- Langone, New York
North CarolinaMission Health, Asheville
OhioUH Cleveland Medical Center, Cleveland
Ohio State University, Columbus
PennsylvaniaUniversity of Pennsylvania, Philadelphia
Allegheny Health Network Research Institute, Pittsburgh
South CarolinaSpartanburg Medical Center, Spartanburg
TexasEl Paso Cardiology Associates, El Paso
Baylor Scott & White Research Institute, Plano
VirginiaSentara, Norfolk
WashingtonUniversity of Washington, Seattle
West VirginiaWest Virginia University- Ruby Memorial, Morgantown

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.